Treating acute myeloid leukemia (AML) depends on knowing what goes wrong inside cells. A new study suggests that two genetic ...
GenScript Biotech Corporation, a global leader in life sciences R&D and manufacturing services, is proud to announce its 5th Annual Biotech Global Forum, scheduled for January 14, 2026, at the San ...
GenScript Biotech Corporation, a global leader in life sciences R&D and manufacturing services, is proud to announce its 5th Annual Biotech Global Forum, scheduled for January 14, 2026, at the San ...
In a report released yesterday, Gregory P Miller from Citizens JMP upgraded Core Scientific Inc to a Buy, with a price target of $30.00. The company’s shares closed yesterday at $14.56. According to ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min 67-year-old company plans move ...
In 1969, a now-iconic commercial first popped the question, “How many licks does it take to get to the Tootsie Roll center of a Tootsie Pop?” This deceptively simple line in a 30-second script managed ...
Investing.com - JMP Securities has reiterated its Market Outperform rating on Core Scientific Inc . (NASDAQ:CORZ), maintaining its positive outlook on the cryptocurrency mining company despite ...
Core Scientific, Inc. (NASDAQ:CORZ) is one of the top bitcoin mining stocks to buy amid bitcoin hike. On July 14, Citizens JMP downgraded Core Scientific, Inc. (NASDAQ:CORZ) to Market Perform from ...
Core Scientific (NASDAQ:CORZ – Get Free Report)‘s stock had its “market perform” rating reiterated by investment analysts at JMP Securities in a research note issued to investors on Monday,Benzinga ...
Hosted on MSN
JMP Securities Downgrades Core Scientific (CORZ)
Fintel reports that on July 14, 2025, JMP Securities downgraded their outlook for Core Scientific (NasdaqGS:CORZ) from Market Outperform to Market Perform. Analyst Price Forecast Suggests 47.48% ...
On May 22, a Citizens JMP analyst initiated coverage of Core Scientific Inc. (NASDAQ:CORZ) with an Outperform rating and a price target of $15. The analyst based his optimistic outlook on Core ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results